BCRXBioCryst Pharmaceuticals, Inc.

$9.82

Is it safe?

Can BCRX take a bad year?

The deepest fall in BCRX's price history on file is −84%; it is −7.3% below its high today.

$43M

Net debt · as at Q2 2026 · debt less the cash on hand

Interest cover
none

Interest cover · no operating profit to pay the interest bill from

Annualised volatility
50%

Annualised volatility · roughly twice as jumpy as the market

Worst drawdown on file
−84%

Worst drawdown on file · −7.3% today

Details
Total debtQ2 2026
$395M
Cash and short-term investments
$353M
Net debt
$43M
EBITDA, trailing twelve months
−$311M
Operating profit, trailing twelve months
−$313M
Annualised volatilitytwo years of daily moves
50%
Worst drawdown on file
−84%
Below its 52-week high
−7.3%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.